IDH2R140Q-IN-2

Modify Date: 2024-03-14 17:27:10

IDH2R140Q-IN-2 Structure
IDH2R140Q-IN-2 structure
Common Name IDH2R140Q-IN-2
CAS Number 2749568-16-7 Molecular Weight 484.40
Density N/A Boiling Point N/A
Molecular Formula C21H18F6N6O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of IDH2R140Q-IN-2


IDH2R140Q-IN-2 (compound 36) is an an orally active IDH2R140Q inhibitor (IC50: 29 nM). IDH2R140Q-IN-2 reduces D2HG production in TF-1 cell lines expressing mutant IDH2R140Q (IC50: 10 nM). IDH2R140Q-IN-2 suppresses D2HG levels in tumor tissue. IDH2R140Q-IN-2 can be used for research of acute myeloid leukemia (AML)[1].

 Names

Name IDH2R140Q-IN-2

 IDH2R140Q-IN-2 Biological Activity

Description IDH2R140Q-IN-2 (compound 36) is an an orally active IDH2R140Q inhibitor (IC50: 29 nM). IDH2R140Q-IN-2 reduces D2HG production in TF-1 cell lines expressing mutant IDH2R140Q (IC50: 10 nM). IDH2R140Q-IN-2 suppresses D2HG levels in tumor tissue. IDH2R140Q-IN-2 can be used for research of acute myeloid leukemia (AML)[1].
Related Catalog
References

[1]. Wei Q, et al. Structure-Based Drug Design of Novel Triaminotriazine Derivatives as Orally Bioavailable IDH2R140Q Inhibitors with High Selectivity and Reduced hERG Inhibitory Activity for the Treatment of Acute Myeloid Leukemia. J Med Chem. 2023 Sep 28;66(18):12894-12910.  

 Chemical & Physical Properties

Molecular Formula C21H18F6N6O
Molecular Weight 484.40